PU
PUGBY
Puig Brands S.A./ADR
$9.70
0.00%
No data for this timeframe.
Vol
Inst. Holders1 funds
Inst. Value$107.00
Inst. Activity0 buys / 1 sells
Recent Activity
Inst.
RHUMBLINE ADVISERS — NEAR_EXIT
11 shares ($108.00)
Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$10.71
Current $9.70
Low $10.71
Median $10.71
High $10.71
1 analysts
$10.71
$10.71
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $0.55 ▲ +1.9% | $0.55 — $0.55 | 6% YoY | 1 |
| Next FY | $0.60 ▲ +1.7% | $0.60 — $0.60 | 9% YoY | 1 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| RHUMBLINE ADVISERS | $107.00 | NEAR_EXIT |
1 institutional holders with $107.00 total value (11 shares) as of 2026-Q1. Top holders: RHUMBLINE.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | RHUMBLINE ADVISERS | 11 | $107.00 | 100.0% | NEAR_EXIT -99.3% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | NEAR_EXIT | 1,587 | 11 | -99.3% | $108.00 | 2025-Q2 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Analyst Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$10.71 mean target
$10.71 Low
$10.71 High
| Metric | Value |
|---|---|
| Current Price | $9.70 |
| Target Low | $10.71 |
| Target Mean | $10.71 |
| Target Median | $10.71 |
| Target High | $10.71 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.2B | — | — |
| Next Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.1B | 2.1% | — |
| Current FY 2026-12-31 |
$0.55 | $0.55 | $0.55 | 5.8% | +1.9% | 0↑ 1↓ | $5.2B | 3.5% | 1 |
| Next FY 2027-12-31 |
$0.60 | $0.60 | $0.60 | 9.1% | +1.7% | 0↑ 1↓ | $5.5B | 5.1% | 1 |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.